Issue 20

The I V I Newsletter

Jan. 2009
Dear friends,
welcome to the 20th edition of The I V I Newsletter.

Watch IVI Video
1.
IVI UPDATE
 
Measuring impact of rotavirus vaccines

IVI studies aim to find evidence about rotavirus disease burden, vaccine safety, efficacy and cost effectiveness for policy makers

 

Rotavirus is a leading cause of severe diarrhea among infants and children under five years of age. Globally, rotavirus disease claims the lives of an estimated 527,000 children each year, with most victims being children in developing countries who have limited access to health care.

The good news is that safe and effective vaccines against rotavirus have recently become licensed internationally, with several additional vaccines now under development. In order for these vaccines to reach those in need, however, it is important to understand rotavirus disease incidence and patterns, experts say...

  

ROK First Lady assumes Honorary Presidency of IVI Support Committee
Madame Kim Yoon-ok, First Lady of the Republic of Korea, was inaugurated as the Honorary President of the Korea Support Committee (KSC) for the International Vaccine Institute (IVI) on October 6...

    
IVI teams up with Crucell to supply emergency cholera vaccines to cyclone-hit Myanmar
The IVI and Crucell, a vaccine producer in the Netherlands, provided cholera vaccine to Myanmar to assist this Southeast Asian country in preventing outbreaks of cholera following... 
 

High bio-containment (BSL 3+) laboratories refurbished at IVI
The IVI recently completed the refurbishment of its new high bio-containment (Biosafety Level 3+) laboratories, which will allow the Institute to take on research to develop vaccines... 

 
IVI scientist wins Grand Challenges Explorations grant from Gates Foundation
The IVI was awarded a grant from the Bill & Melinda Gates Foundation for a pioneering project to develop an effective influenza vaccine on October 22, 2008. The project, led by Dr. Huan...
Events
2.
PUBLICATIONS
 
Strategic Plan 2008-2012 (New)
 
Annual Report 2006-2007
 
Brochure
  Previous issues of the IVI Newsletter
  PDVI Newsletters
  Publications by IVI staff
   
3.
FRIENDS OF IVI
 

Yang-Hyun Foundation becomes first 'Giving Partner of IVI'
Yang-Hyun Foundation of Korea became the first "Giving Partner" of the IVI through a 50 million won donation to the Institute. The Foundation was appointed as an "IVI Giving Partner"...

'Science Leadership Course' conducted to nurture future global leaders
The IVI held a six-day training course for 63 talented high school students as part of the IVI Science Leadership Program (SLP) during September 1-6 at IVI's headquarters...
Photo exhibition on the environment held in support of IVI
Photographer Kang Jeauk held an exhibition, "Tristes tropiques (Sad Tropics)," from November 5 to 11 at Insa Art Center in Insa-dong, Seoul...

Korea's television stations air IVI's PSA
Korea Broadcasting System, a public broadcaster with the largest national network, aired 15 spots of IVI's public service announcement via KBS 1 TV channel during...

 
IVI Support Comittee elects Prof. Park Sang-Dai as new President and Chairman
The Korea Support Committee for the IVI elected Emeritus Professor Park Sang-Dai of Seoul National University as its third President and Chairman of the Board of Trustees...
 
Donors list

I V I (International Vaccine Institute)
TEL:
82-2-881-1222        FAX : 82-2-881-1228
WEB : www.ivi.int
E-mail : newsletter@ivi.int
ADDRESS : International Vaccine Institute, Kwanak PO Box 14, Seoul, Korea 151-919